Jesteś w trybie podpowiedzi Wyłącz

Cencora, ordinary share
US03073E1055, COR

Cencora, państwo — USA
Brak danych dla licytacji
Można przełączyć wyświetlanie danych Wykres / tabela
Źródło informacji – PJSC "Moskiewska giełda". Dalsze powielanie informacji bez uprzedniego uzgodnienia z PJSC "Moskiewska giełda" zabronione.
Źródło informacji – PJSC "Moskiewska giełda". Dalsze powielanie informacji bez uprzedniego uzgodnienia z PJSC "Moskiewska giełda" zabronione.
od
do
ADD-IN
program uzupełniający Cbonds
API
bond data api
Należy się zalogować
Potrzebny jest dostęp
Znaleziono ponad 2500 zapisów, proszę uściślić zapytanie
Brak danych dla wybranego okresu

Ostatnie notowania

poznaj najbardziej kompletną bazę danych

800 000

obligacje na całym świecie

Ponad 400

źródła kształtowania cen

80 000

akcje

9 000

ETF

najskuteczniej kontroluj swój portfel
skaner obligacji
Lista do obejrzenia
DODATEK Excel

Emitent

Profil
Cencora Inc is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to ...
Cencora Inc is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers.
  • Emitent
  • Pełna nazwa kredytobiorcy/emitenta
    Cencora Inc
  • Branża
    Handel hurtowy

Identyfikatory

Aktualne wiadomości

2024-04-17 Cencora: Entry Into Material Definitive Agreement, Creation Of Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Financial Statements And Exhibits
2024-03-28 Moody's Investors Service revised outlook on Cencora to positive and affirmed at "Baa2" (LT- local currency) credit rating
2024-03-12 Cencora: Amendment To Articles Of Incorporation Or Bylaws, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
2024-03-11 Cencora: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangement Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
2024-03-11 Cencora: Of The Current Report On Form 8k Filed On March 12, 2024 (the Original Form 8k ) By Cencora, Inc. (the Company ), Which Disclosed (i) That Steven H. Collis Will Retire From The Role Of Chief Executive Officer ( Ceo ) Effective October 1, 2024 (the Effective Date ) And Become Executive Chairman Of The Board Of Directors Of The Company (the Board ) As Of Such Date And (ii) The Appointment Of Robert P. Mauch As The Company S President And Ceo, As Of The Effective Date, At Which Time Mr. Mauch Will Also Join The Board. The Sole Purpose Of This Amendment Is To Provide Messrs. Collis And Mauch S Compensation Arrangements In Connection With Their New Positions As Of The Effective Date, Financial Statements And Exhibits
Wszystkie aktualności organizacji

Posiadacze instytucjonalne

Liderzy branży

Należy zarejestrować się , aby uzyskać dostęp.